Evidence map›Paper›PMID 35571872›Full record

ArticlePharmaceutical chemistry journal2022

Ensuring Viral Safety of Equine Immunoglobulins during Production.

V V Mashin, A N Sergeev, N N Martynova, M D Oganov, A A Sergeev, V V Kataeva, N V Zagidullin

Abstract read
In one paragraph

Article in Pharmaceutical chemistry journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

V V MashinMicrogen Scientific Industrial Company for Immunobiological Medicines JSC, 10 2nd Volkonskii Pereulok, Moscow, 127473 Russia.
A N SergeevMicrogen Scientific Industrial Company for Immunobiological Medicines JSC, 10 2nd Volkonskii Pereulok, Moscow, 127473 Russia.
N N MartynovaMicrogen Scientific Industrial Company for Immunobiological Medicines JSC, 10 2nd Volkonskii Pereulok, Moscow, 127473 Russia.
M D OganovMicrogen Scientific Industrial Company for Immunobiological Medicines JSC, 10 2nd Volkonskii Pereulok, Moscow, 127473 Russia.
A A SergeevAVVAPharmaceuticals Ltd., Representative Moscow Office, Office 8, 4/3 Aviamotornaya St., Moscow, 111116 Russia.
V V KataevaMicrogen Scientific Industrial Company for Immunobiological Medicines JSC, 10 2nd Volkonskii Pereulok, Moscow, 127473 Russia.
N V ZagidullinMicrogen Scientific Industrial Company for Immunobiological Medicines JSC, 10 2nd Volkonskii Pereulok, Moscow, 127473 Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Equine blood plasma/serum and intermediates must be monitored for the presence of live viruses pathogenic in humans during production of equine immunoglobulins. Information concerning low-cost and simple methods for the detection of live horse viruses pathogenic and non-pathogenic to humans was gained using data of modern domestic and foreign literature. These methods are based on cultivation of these viruses on sensitive biosystems. The presented information can be used to set up blood plasma/serum control of horses at different stages of immunoglobulin production, i.e., when taking blood from horses during their quarantine period, when collecting blood from immunized horses, and before bottling the medicinal intermediate in the primary package.

Indexed as

cultivation biosystemdetection methodduration of cultivationequine immunoglobulinequine virus

Identifiers

PMID35571872
PMCPMC9076163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.